SRx Health Solutions, Inc. · AMEX:SRXH

SRx Health Solutions, Inc. financial statements

SRx Health Solutions, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2025FY2024FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue6.53M35.0M38.6M54.7M46.0M42.6M15.6M14.8M475
Cost of revenue5.01M22.0M26.8M39.4M30.6M26.5M9.72M7.49M211
Gross profit1.53M13.0M11.8M15.3M15.4M16.1M5.86M7.30M264
Research and development100.0K100.0K500.0K500.0K100.0K
Selling, general and administrative12.9M19.0M24.4M35.4M28.5M34.5M
Operating income-11.4M-5.97M-21.2M-38.8M-17.3M-27.3M-36.3M-5.16M-527.9K
Depreciation and amortization31.0K130.0K4.39M1.68M1.69M1.66M1.75M171.0K14.0K
EBITDA-11.4M-5.84M-19.5M-37.1M-15.6M-25.6M-36.2M-5.14M
Interest expense628.0K467.0K1.35M551.0K9.20M700.0K868.0K532.9K
Income before tax-8.64M-159.0K-22.8M-39.3M3.42M-59.3M-1.11M
Income tax9.00K2.00K-18.0K37.0K000
Net income-45.0M-168.0K-43.1M-22.8M-39.3M3.39M-59.3M-184.5M-6.03M-2.95M
Earnings per share, basic-2.13-0.10-1.95-32.29-58.930.15-7.26-5.55-0.52-0.98
Earnings per share, diluted-2.13-0.10-1.95-32.29-58.930.14-7.26-5.55-0.52-0.98

Balance sheet

LineFY2025FY2025FY2024FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents1.31M3.07M106.0K4.46M3.17M21.7M3.93M2.36M3.95M199.7K
Receivables3.94M5.37M9.28M4.35M6.74M6.79M4.63M5.82M116.0K
Inventory2.08M3.87M3.37M6.61M10.3M5.25M4.87M6.58M1.56M9.40K
Current assets8.13M15.0M13.6M16.2M27.5M43.9M17.6M17.6M5.89M209.1K
Property, plant and equipment88.0K138.0K6.03M230.0K375.0K369.0K252.0K417.0K71.0K
Goodwill405.0K405.0K018.6M18.6M18.6M0
Total assets8.40M15.8M33.8M16.7M38.7M74.7M51.3M53.5M5.99M209.1K
Accounts payable2.15M3.14M39.8M6.93M2.93M4.55M3.14M4.05M765.0K39.1K
Current liabilities3.54M7.15M81.3M13.7M5.58M7.34M54.6M33.0M9.03M2.86M
Long-term debt02.41M696.0K11.4M9.41M24.6M16.4M00
Total debt02.41M36.0M4.62M11.6M10.3M32.6M37.3M6.20M1.03M
Total liabilities8.00M7.15M88.9M13.8M17.1M16.8M79.4M50.0M9.03M
Shareholders' equity407.0K-63.7M-55.1M2.95M21.5M57.9M-28.1M-7.07M-3.04M-2.65M
Shares outstanding416.5K1.83M22.5M729.0K668.9K29.1M8.65M48.0M11.7M3.06M

Cash flow

LineFY2025FY2025FY2024FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-8.14M-4.36M-1.48M97.0K-20.6M-11.9M-7.50M-21.0M-6.90M-842.4K
Capital spending-41.0K-18.0K-198.0K-353.0K-151.0K-110.0K-31.0K
Free cash flow-4.40M79.0K-20.8M-12.2M-7.66M-21.1M-6.93M
Cash from investing5.91M-2.25M-1.09M-18.0K-198.0K-353.0K-151.0K-20.2M-31.0K0
Cash from financing12.2M5.22M932.0K-5.10M1.28M37.2M9.11M39.8M10.7M1.00M
Share buybacks0-1.60M00
Change in cash1.41M-1.39M-1.64M-5.02M-19.5M25.0M1.46M-1.41M3.79M159.1K